CHICAGO, Ill., Nov. 23,
2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) will
participate in the 5th Annual Evercore ISI Virtual
HealthCONx Conference on Tuesday, November
29, 2022. Rob Michael, vice
chairman and president, Jeffrey R.
Stewart, executive vice president, commercial operations,
Scott Reents, senior vice president
and chief financial officer, and Tom
Hudson senior vice president, R&D and chief scientific
officer, will present at 9:55 a.m. Central
A live audio webcast of the presentation will be accessible
through AbbVie's Investor Relations website at
investors.abbvie.com. An archived edition of the session will be
available later that day.
AbbVie's mission is to discover and deliver innovative medicines
that solve serious health issues today and address the medical
challenges of tomorrow. We strive to have a remarkable impact on
people's lives across several key therapeutic areas: immunology,
oncology, neuroscience, eye care, virology, and women's health, in
addition to products and services across our Allergan Aesthetics
portfolio. For more information about AbbVie, please visit us
at www.abbvie.com. Follow @abbvie on Twitter, Facebook,
Instagram, YouTube and LinkedIn.